+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Therapeutic Area Market Research Reports

From
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
From
T-Cell Immunotherapy Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

T-Cell Immunotherapy Market - Forecasts from 2025 to 2030

  • Report
  • October 2025
  • 142 Pages
  • Global
From
Celiac Disease Treatment Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Celiac Disease Treatment Market - Forecasts from 2025 to 2030

  • Report
  • August 2025
  • 145 Pages
  • Global
From
Myasthenia Gravis Treatment Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Myasthenia Gravis Treatment Market - Forecasts from 2025 to 2030

  • Report
  • January 2025
  • 142 Pages
  • Global
From
Pediatric Vaccine Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Pediatric Vaccine Market - Forecasts from 2024 to 2029

  • Report
  • May 2024
  • 130 Pages
  • Global
From
Loading Indicator

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs. Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more